Inventor

Michael D. Kaytor

Inventor
Maplewood, MN, US

Overview

17→
Patents
2010–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 17 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes31%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations20%
C12NMicroorganisms or enzymes16%
A23KFodder11%
A23LFoods, foodstuffs or non-alcoholic beverages, not otherwise provided for11%
A61MDevices for introducing media into, or onto, the body7%
A61NElectrotherapy2%
C12YEnzymes2%
PatentTitleYear
11,129,894Sensitizing cells to proton radiation202110,314,812Suspension compositions of physiologically active phenolic compounds and methods of making and using the same201910,220,018Method of mitigating long and short term detrimental effects of exposure to low dose ionizing radiation by administration of genistein201910,016,514Polynucleotides, vectors and methods for insertion and expression of transgenes20189,993,455Method of mitigating long term detrimental effects of exposure to medical imaging ionizing radiation by administration of genistein20189,937,148Suspension compositions of physiologically active phenolic compounds and methods of making and using the same20189,782,384'Suspension compositions of physiologically active phenolic compounds and methods of making and using the same'20179,623,004'Administration of a therapeutic amount of genistein to mitigate erectile dysfunction resulting from radiation therapy for prostate cancer only throughout a defined administration period commencing shortly before and concluding after radiation therapy'20179,623,003'Method of mitigating long and short term detrimental effects of exposure to medical imaging ionizing radiation by administration of genistein'20179,387,171'Suspension compositions of physiologically active phenolic compounds and methods of making and using the same'20169,084,726'Suspension compositions of physiologically active phenolic compounds and methods of making and using the same'20158,957,198'Compositions, devices and methods for treatment of Huntington\'s disease through intracranial delivery of sirna'20158,557,975'Methods and sequences to suppress primate Huntington gene expression'20138,258,112'Methods and sequences to suppress primate huntington gene Expression'20127,994,149'Method for treatment of Huntington\'s disease through intracranial delivery of sirna'20117,902,352'Isolated nucleic acid duplex for reducing huntington gene expression'20117,732,591'Compositions, devices and methods for treatment of huntington\'s disease through intracranial delivery of sirna'2010

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2010–2015Patents assigned to MEDTRONIC INC (6)· patent assignee history
2010–2021Based in Maplewood, MN, US· patent location history
2012–2015Patents assigned to KAEMMERER WILLIAM F (3)· patent assignee history
2012–2015Patents assigned to KAYTOR MICHAEL D (3)· patent assignee history
2015–2021Patents assigned to HUMANETICS CORP (10)· patent assignee history
2018Patents assigned to NEW HOPE RES FOUNDATION (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
HUMANETICS CORP102015–2021
MEDTRONIC INC62010–2015
KAEMMERER WILLIAM F32012–2015
KAYTOR MICHAEL Dself32012–2015
NEW HOPE RES FOUNDATION12018
Locations
LocationPatentsSpan
Maplewood, Minnesota, US172010–2021